Bruce D. Broussard reports 795 Takeda (NYSE: TAK) American Depositary Shares
Rhea-AI Filing Summary
Takeda Pharmaceutical Co. Ltd. director Bruce D. Broussard filed an initial Form 3 reporting his holdings in the company. The filing shows he directly owns 795 American Depositary Shares as of the reported date. This is a baseline disclosure of his beneficial ownership rather than a new buy or sell transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
BROUSSARD BRUCE D
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | American Depositary Shares | -- | -- | -- |
Holdings After Transaction:
American Depositary Shares — 795 shares (Direct)
Key Figures
ADS holdings: 795 American Depositary Shares
Form type: Form 3
Reporting role: Director
3 metrics
ADS holdings
795 American Depositary Shares
Direct ownership following reported entry
Form type
Form 3
Initial statement of beneficial ownership
Reporting role
Director
Status of Bruce D. Broussard at issuer
Key Terms
American Depositary Shares, Form 3, beneficial ownership
3 terms
Form 3 regulatory
"INSIDER FILING DATA (Form 3)"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
beneficial ownership regulatory
"initial statement of beneficial ownership by a reporting insider"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Bruce D. Broussard’s Form 3 for TAKEDA PHARMACEUTICAL CO LTD show?
The Form 3 shows Bruce D. Broussard, a director of Takeda, directly owns 795 American Depositary Shares. This is an initial beneficial ownership report, establishing his starting position rather than indicating a new purchase or sale.
What type of security is reported in Bruce D. Broussard’s Takeda Form 3?
The security reported is American Depositary Shares of Takeda Pharmaceutical Co. Ltd. The Form 3 indicates direct ownership of 795 of these ADS, which are a way for investors to hold interests in a non-U.S. company’s shares.
Does the Takeda Form 3 for Bruce D. Broussard include any derivative securities?
The Form 3 data provided shows no derivative securities for Bruce D. Broussard. Only 795 American Depositary Shares are listed as directly owned, and the derivative securities section is empty in this filing snapshot.